As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

India's benchmark indexes opened lower on Thursday after U.S. President Donald Trump slapped 26% reciprocal tariffs on ...

European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three ...

The delisting action was determined after Virpax Pharmaceuticals failed to regain compliance with Nasdaq Listing Rule 5550 (b) (1). The delisting process will conclude with the filing of a Form 25 ...

President Trump has announced sweeping tariffs on several countries. Novo Nordisk and Smith & Nephew may be the most at risk ...

US President Donald Trump’s 26% reciprocal tariff on India is expected to have the greatest impact on the automotive, IT, and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The exemption given to Indian pharmaceuticals is positive and, therefore, this segment is likely to witness buying, says ...

Shares of Phathom Pharmaceuticals fell after the company said Chief Executive Officer Terrie Curran has resigned and will be succeeded by SaNOtize's Steven Basta. The stock declined 22% to $4.88 on ...

European shares fell on Wednesday, weighed by losses in healthcare stocks, as investors awaited tariff plans from U.S.